Literature DB >> 13523414

A test for myocardial infarction; the present status of the use of serum lactic acid dehydrogenase.

H T WILSON, J A LAZARONI, E C MAIER.   

Abstract

Determination of the amount of lactic acid dehydrogenase in the blood has been demonstrated as a useful aid in the diagnosis of myocardial necrosis. The reliability of the test and the time element of the appearance and disappearance of the enzyme in the blood give it advantages over transminase determinations. In addition there appears to be a correlation of lactic acid dehydrogenase content with metastatic carcinoma. The levels of the substance correlate with the presence or absence of metastatic lesions and also with the extent of the metastasis. Few other clinical states are associated with increased levels of this enzyme, and in most instances the few that are can be excluded by other reliable criteria.

Entities:  

Keywords:  DEHYDROGENASES/in blood; MYOCARDIAL INFARCT/blood in

Mesh:

Substances:

Year:  1958        PMID: 13523414      PMCID: PMC1512428     

Source DB:  PubMed          Journal:  Calif Med        ISSN: 0008-1264


  6 in total

1.  Lactic dehydrogenase activity in blood.

Authors:  F WROBLEWSKI; J S LADUE
Journal:  Proc Soc Exp Biol Med       Date:  1955-10

2.  Serum lactic dehydrogenase; a diagnostic aid in myocardial infarction.

Authors:  R P MACDONALD; J R SIMPSON; E NOSSAL
Journal:  J Am Med Assoc       Date:  1957-09-07

3.  Lactic dehydrogenase activity in human serum.

Authors:  H G WEINSTEIN; H J ZIMMERMAN
Journal:  J Lab Clin Med       Date:  1956-10

4.  Serum enzymes. I. Serum lactic dehydrogenase in myocardial infarction.

Authors:  L P WHITE
Journal:  N Engl J Med       Date:  1956-11-22       Impact factor: 91.245

5.  Metalloenzymes and myocardial infarction. II. Malic and lactic dehydrogenase activities and zinc concentrations in serum.

Authors:  D D ULMER; B L VALLEE; W E WACKER
Journal:  N Engl J Med       Date:  1956-09-06       Impact factor: 91.245

6.  Elevation of a serum component in neoplastic disease.

Authors:  B R HILL; C LEVI
Journal:  Cancer Res       Date:  1954-08       Impact factor: 12.701

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.